Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Jacopo, Mariotti"'
Autor:
Clara Di Vito, Nicolò Coianiz, Michela Calvi, Sara Terzoli, Elisa Zaghi, Simone Puccio, Alessandro Frigo, Jacopo Mariotti, Chiara De Philippis, Daniele Mannina, Barbara Sarina, Rossana Mineri, Vu Thuy Khanh Le-Trilling, Mirko Trilling, Luca Castagna, Stefania Bramanti, Armando Santoro, Domenico Mavilio
Publikováno v:
Frontiers in Immunology, Vol 14 (2024)
Haploidentical hematopoietic stem cell transplantation (h-HSCT) is a therapeutic option to cure patients affected by hematologic malignancies. The kinetics and the quality of immune-reconstitution (IR) impact the clinical outcome of h-HSCT and limit
Externí odkaz:
https://doaj.org/article/ff1e1518e9bd4fbda530dbd55204e118
Autor:
Jacopo Mariotti, Francesca Ricci, Laura Giordano, Daniela Taurino, Barbara Sarina, Chiara De Philippis, Daniele Mannina, Carmelo Carlo-Stella, Stefania Bramanti, Armando Santoro
Publikováno v:
Cells, Vol 13, Iss 2, p 118 (2024)
The introduction of novel drugs (PD-1 inhibitors and/or brentuximab vedotin) into salvage regimens has improved the response rate and the outcome of patients with relapsed/refractory Hodgkin lymphoma. However, the impact of new drugs on the outcome h
Externí odkaz:
https://doaj.org/article/f2ce499b378d40158dae1debf3e814fc
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/c810afac6b514e73a5464e1925c8ba70
Autor:
Jacopo Mariotti, Daniela Taurino, Fabrizio Marino, Stefania Bramanti, Barbara Sarina, Lucio Morabito, Chiara De Philippis, Clara Di Vito, Domenico Mavilio, Carmelo Carlo‐Stella, Matteo Della Porta, Armando Santoro, Luca Castagna
Publikováno v:
Cancer Medicine, Vol 9, Iss 1, Pp 52-61 (2020)
Abstract Cytokine release syndrome (CRS) represents a life‐threatening side effect after haploidentical stem cell transplantation (Haplo‐SCT) with posttransplant cyclophosphamide (PT‐Cy). Factors predictive of CRS development is still a matter
Externí odkaz:
https://doaj.org/article/99e62eeddf6c46e0b49324a1098a5134
Autor:
Giuseppe Lia, Clara Di Vito, Stefania Bruno, Marta Tapparo, Lucia Brunello, Armando Santoro, Jacopo Mariotti, Stefania Bramanti, Elisa Zaghi, Michela Calvi, Lorenzo Comba, Martina Fascì, Luisa Giaccone, Giovanni Camussi, Eileen M. Boyle, Luca Castagna, Andrea Evangelista, Domenico Mavilio, Benedetto Bruno
Publikováno v:
Frontiers in Immunology, Vol 12 (2022)
Even with high-dose post-transplant cyclophosphamide (PT-Cy) which was initially introduced for graft-versus-host disease (GvHD) prevention in the setting of HLA-haploidentical transplantation, both acute and chronic GvHDs remain a major clinical cha
Externí odkaz:
https://doaj.org/article/4d2407bf0bf8413989b037ba34433948
Autor:
Jasper J. P. van Beek, Simone Puccio, Alessandra Roberto, Federica De Paoli, Giulia Graziano, Elisa Salviato, Giorgia Alvisi, Veronica Zanon, Alice Scarpa, Elisa Zaghi, Michela Calvi, Clara Di Vito, Rossana Mineri, Barbara Sarina, Chiara De Philippis, Armando Santoro, Jacopo Mariotti, Stefania Bramanti, Francesco Ferrari, Luca Castagna, Domenico Mavilio, Enrico Lugli
Publikováno v:
Haematologica, Vol 106, Iss 10 (2021)
Externí odkaz:
https://doaj.org/article/8835ea38efbf46e0834e70bf9e5a3d33
Autor:
Elisa Zaghi, Michela Calvi, Simone Puccio, Gianmarco Spata, Sara Terzoli, Clelia Peano, Alessandra Roberto, Federica De Paoli, Jasper J.P. van Beek, Jacopo Mariotti, Chiara De Philippis, Barbara Sarina, Rossana Mineri, Stefania Bramanti, Armando Santoro, Vu Thuy Khanh Le-Trilling, Mirko Trilling, Emanuela Marcenaro, Luca Castagna, Clara Di Vito, Enrico Lugli, Domenico Mavilio
Publikováno v:
JCI Insight, Vol 6, Iss 12 (2021)
Haploidentical hematopoietic stem cell transplantation (h-HSCT) represents an efficient curative approach for patients affected by hematologic malignancies in which the reduced intensity conditioning induces a state of immunologic tolerance between d
Externí odkaz:
https://doaj.org/article/0a56f5f4bf464fbf844eb17c2cc2c103
Autor:
Jacopo Mariotti, Anna Maria Raiola, Andrea Evangelista, Samia Harbi, Francesca Patriarca, Michele Angelo Carella, Massimo Martino, Antonio Risitano, Alessandro Busca, Luisa Giaccone, Lucia Brunello, Emanuela Merla, Lucia Savino, Barbara Loteta, Giuseppe Console, Renato Fanin, Alessandra Sperotto, Luana Marano, Serena Marotta, Camilla Frieri, Simona Sica, Patrizia Chiusolo, Christian Chabannon, Sabine Furst, Armando Santoro, Andrea Bacigalupo, Benedetto Bruno, Didier Blaise, Domenico Mavilio, Stefania Bramanti, Raynier Devillier, Emanuele Angelucci, Luca Castagna
Publikováno v:
Bone Marrow Transplantation. 57:1758-1764
Donor selection may contribute to improve clinical outcomes of T cell-replete haploidentical stem cell transplantation (Haplo-SCT) with post-transplant cyclophosphamide (PT-Cy). Impact of second-degree related donor (SRD) was not fully elucidated in
Autor:
Jacopo Mariotti, Paolo Corradini, Anisa Bermema, Davide Confalonieri, Camilla Recordati, Antonio Vendramin, Silvia Gimondi, Cristiana Carniti
Supplementary Figures S1-6. Figure S1: Histological staging criteria for acute GvHD Figure S2: Ruxolitinib does not impair post-transplant donor myeloid reconstitution and full donor chimerism. Figure S3: GVT effect against myeloid leukemia RMB-1 cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5eda3ce0e9027b4cfc75a265b96217bd
https://doi.org/10.1158/1078-0432.22457555
https://doi.org/10.1158/1078-0432.22457555
Autor:
Jacopo Mariotti, Paolo Corradini, Anisa Bermema, Davide Confalonieri, Camilla Recordati, Antonio Vendramin, Silvia Gimondi, Cristiana Carniti
Purpose: Immune-mediated graft-versus-tumor (GVT) effects can occur after allogeneic hematopoietic stem cell transplantation (HSCT), but GVT is tightly linked to its main complication, graft-versus-host disease (GVHD). Strategies aimed at modulating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b3eee6f6de4d21647789f041285498
https://doi.org/10.1158/1078-0432.c.6523616
https://doi.org/10.1158/1078-0432.c.6523616